Abstract:Background Irritable bowel syndrome with diarrhea (IBS-D) is a chronic functional gastrointestinal disorder that has a significant impact on quality of life, work productivity, and healthcare resources. External therapy of traditional Chinese medicine (TCM) has positive effects on IBS-D and is simple, convenient, and low-cost. This study aimed to systematically evaluate the efficacy and safety of external therapy of TCM for IBS-D. Methods This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP), Wan Fang, and Chinese Biomedical (CBM) databases were electronically searched to collect randomized controlled trials comparing external therapy of TCM with Western medicine for IBS-D from inception to 31 December 2021. Two authors independently screened, extracted, and assessed the selected studies. The Jadad scale and Cochrane Collaboration Risk of Bias tool were used to evaluate study quality. The certainty of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE). The meta-analysis was performed using the Review Manager software (version 5.3). Results Twenty-one studies involving 1,862 subjects were included. Acupuncture and moxibustion were the most commonly used external therapies. The meta-analysis showed that based on total effective rate with moderate certainty of evidence ( n = 21 studies, n = 1,862 participants, RR = 1.25, 95% CI [1.2, 1.31], I 2 = 0%, P < 0.00001), clinical cure rate with low certainty of evidence ( n = 17 studies, n = 1,502 participants, RR = 1.66, 95% CI [1.4, 1.96], I 2 = 1%, P < 0.00001), recurrence rate with very low certainty of evidence ( n = 5 studies, n = 260 participants, RR = 0.44, 95% CI [0.34, 0.58], I 2 = 0%, P < 0.00001), total symptom score (MD = −4.9, 95% CI [−7.34, −2.47]), and IBS severity scoring system score (IBS-SSS) with moderate certainty of evidence (MD = −52.72, 95% CI [−63.9, −41.53]), the experimental group had significant advantages compared with the control group. The sensitivity analysis further confirmed the robustness of the primary outcomes. The improvement in quality of life associated with IBS (IBS-QOL) was superior in the experimental group compared to the control group, and the difference was statistically significant; however, the clinical heterogeneity was strong. The inverted funnel plot of the included studies indicated a potential publication bias. Conclusion External therapy of TCM for IBS-D alleviated abdominal symptoms, improved clinical effectiveness, and reduced recurrence with great safety. However, because of the limitations of publication bias in trials, more rigorous studies with a clinical design are necessary for further verification of the outcomes. Systematic Review Registration [ https://www.crd.york.ac.uk/PROSPERO/ ], identifier [CRD42020222993].

Bridging the Gap: A Comprehensive Study on Traditional Chinese Medicine Strategies for Managing Adult Irritable Bowel Syndrome

The Diagnosis Performance of the TCM Syndromes of Irritable Bowel Syndrome by Gastroenterologists Based on Modified Simple Criteria Compared to TCM Practitioners: A Prospective, Multicenter Preliminary Study

International standard of Traditional Chinese Medicine techniques: clinical guidelines for dysmenorrhea (2022)

Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings

Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials

Treatment of Diarrhea-Predominant Irritable Bowel Syndrome with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Trial

Enhancing Clinical Efficacy Through the Gut Microbiota: A New Field of Traditional Chinese Medicine

Traditional Chinese Medicine Based Subgrouping of Irritable Bowel Syndrome Patients

External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis

Traditional Chinese medicine for functional gastrointestinal disorders and inflammatory bowel disease: narrative review of the evidence and potential mechanisms involving the brain-gut axis

[Some Ideas Regarding Establishment of Chinese Medicine Clinical Assessment Indices System for Studying Irritable Bowel Syndrome].

Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome.

Considerations of Traditional Chinese Medicine as Adjunct Therapy in the Management of Ulcerative Colitis

Study on clinical significance of different subgroups of irritable bowel syndrome patients in Zhejiang province

Standardizing and optimizing acupuncture treatment for irritable bowel syndrome: A Delphi expert consensus study

Exploration of the mechanism of Traditional Chinese Medicine for anxiety and depression in patients with diarrheal irritable bowel syndrome based on network pharmacology and meta-analysis

Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials

Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management

Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment

Bibliometric analysis of traditional Chinese medicine in the treatment of inflammatory bowel disease

Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal flora